You are viewing Allergic Living Canada | Switch to United States

Talking Allergies

* FAQ    * Search
* Login   * Register
It is currently Sat Jul 04, 2020 5:55 am

All times are UTC - 4 hours

Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Sat Aug 13, 2016 9:00 am 

Joined: Thu Dec 20, 2007 7:23 pm
Posts: 1099
Location: Kingston
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) (PALISADE)

Detailed Description:
This is an international, multicenter, randomized, double-blind, placebo-controlled study of the efficacy and safety of AR101 in a characterized desensitization oral immunotherapy regimen in peanut-allergic individuals.


Ages Eligible for Study: 4 Years to 55 Years (Child, Adult)
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No

Key Inclusion Criteria:

Age 4 through 55 years
Clinical history of allergy to peanuts or peanut-containing foods
Serum immunoglobulin E (IgE) to peanut ≥0.35 kUA/L (kilos of allergen-specific units per liter, determined by UniCAP™* within the past 12 months) and/or a skin prick test (SPT) to peanut ≥3 mm compared to control
Experience dose-limiting symptoms at or before the 100 mg challenge dose of peanut protein (measured as 200 mg of peanut flour) on Screening DBPCFC conducted in accordance with PRACTALL** guidelines
Not be residing at the same address as another subject in this or any peanut OIT study ... 1#contacts


Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 4 hours

Who is online

Users browsing this forum: No registered users and 0 guests

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Search for:
Jump to:  
Powered by phpBB® Forum Software © phpBB Group